Stroke is the leading cause of severe disability and the third leading cause of death, accounting for 1 of every 15 deaths in the United States. We investigated the association of polymorphisms in the soluble epoxide hydrolase gene (EPHX2) with incident ischemic stroke in African-Americans and Whites. Twelve single nucleotide polymorphisms (SNPs) spanning EPHX2 were genotyped in a case-cohort sample of 1,336 participants from the Atherosclerosis Risk in Communities (ARIC) study. In each racial group, Cox proportional hazard models were constructed to assess the relationship between incident ischemic stroke and EPHX2 polymorphisms. A score test method was used to investigate the association of common haplotypes of the gene with risk of ische...
Abstract—Cytochrome P450-derived epoxyeicosatrienoic acids are potent vasodilators in preclinical mo...
The genetic architecture of ischemic stroke is complex and is likely to include rare or low frequenc...
Stroke genetics includes several topics of clinical interest, including (1) molecular genetic variat...
Stroke is the leading cause of severe disability and the third leading cause of death, accounting fo...
Genetic variation in the EPHX2 gene region has been reported to influence susceptibility to ischemic...
Purpose: Soluble epoxide hydrolase (sEH) and microsomal epoxide hydrolase (mEH) both catalyze the me...
Endothelial dysfunction contributes to the development of coronary heart disease (CHD). Soluble epox...
OBJECTIVES: The soluble epoxide hydrolase (gene name EPHX2) is responsible for metabolism of 8,9 11,...
Stroke is characterized with loss of one or more functions of the body resulted by inadequate blood ...
Cytochrome P450-derived epoxyeicosatrienoic acids are potent vasodilators in preclinical models and ...
Soluble epoxide hydrolase 2 (EPHX2) is an enzyme promoting increased cellular apoptosis through indu...
Inhibition of soluble epoxide hydrolase (sEH, EPHX2) elicits potent cardiovascular protective effect...
Stroke is the second leading cause of death and the third leading cause of years of life lost. Genet...
IMPORTANCE Stroke is the second leading cause of death and the third leading cause of years of life ...
BACKGROUND: Genome-wide association studies (GWAS) have identified loci associated with ischemic str...
Abstract—Cytochrome P450-derived epoxyeicosatrienoic acids are potent vasodilators in preclinical mo...
The genetic architecture of ischemic stroke is complex and is likely to include rare or low frequenc...
Stroke genetics includes several topics of clinical interest, including (1) molecular genetic variat...
Stroke is the leading cause of severe disability and the third leading cause of death, accounting fo...
Genetic variation in the EPHX2 gene region has been reported to influence susceptibility to ischemic...
Purpose: Soluble epoxide hydrolase (sEH) and microsomal epoxide hydrolase (mEH) both catalyze the me...
Endothelial dysfunction contributes to the development of coronary heart disease (CHD). Soluble epox...
OBJECTIVES: The soluble epoxide hydrolase (gene name EPHX2) is responsible for metabolism of 8,9 11,...
Stroke is characterized with loss of one or more functions of the body resulted by inadequate blood ...
Cytochrome P450-derived epoxyeicosatrienoic acids are potent vasodilators in preclinical models and ...
Soluble epoxide hydrolase 2 (EPHX2) is an enzyme promoting increased cellular apoptosis through indu...
Inhibition of soluble epoxide hydrolase (sEH, EPHX2) elicits potent cardiovascular protective effect...
Stroke is the second leading cause of death and the third leading cause of years of life lost. Genet...
IMPORTANCE Stroke is the second leading cause of death and the third leading cause of years of life ...
BACKGROUND: Genome-wide association studies (GWAS) have identified loci associated with ischemic str...
Abstract—Cytochrome P450-derived epoxyeicosatrienoic acids are potent vasodilators in preclinical mo...
The genetic architecture of ischemic stroke is complex and is likely to include rare or low frequenc...
Stroke genetics includes several topics of clinical interest, including (1) molecular genetic variat...